Cordova Ashley 4
4 · NovoCure Ltd · Filed Feb 29, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Cordova Ashley
Former Chief Executive Officer
Transactions
- Award
Ordinary Shares
2024-02-27$16.30/sh+102,249$1,666,659→ 219,867 total - Award
Stock Options (Right to buy)
2024-02-27$16.30/sh+156,348$2,548,472→ 156,348 totalExercise: $16.30From: 2025-02-27Exp: 2034-02-26→ Ordinary Shares (156,348 underlying)
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 156,348 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.